Vestal Point Capital’s Bright Minds Biosciences DRUG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$27.2M Hold
545,000
– – 0.7% 24
2026
Q2
$38.3M Buy
545,000
+52,681
+11% +$4.14M 0.89% 31
2026
Q1
$35.9M Buy
+492,319
New +$39.6M 1% 36

Other funds holding DRUG

Vestal Point Capital's DRUG Position: Q3 2026 in Review

Vestal Point Capital held its Bright Minds Biosciences (DRUG) position steady in Q3 2026 at 545,000 shares worth $27.2M. The position accounts for 0.7% of the portfolio, ranked #24.

Vestal Point Capital first reported a position in DRUG in Q1 2026 and has held it in 3 quarters since. The position peaked at $38.3M in Q2 2026. 110 funds tracked by Wall St. Rank hold DRUG as of Q3 2026.

  • Vestal Point Capital held 545,000 shares of Bright Minds Biosciences worth $27.2M as of Q3 2026.
  • Vestal Point Capital left its Bright Minds Biosciences share count unchanged in Q3 2026.
  • Bright Minds Biosciences made up 0.7% of Vestal Point Capital's portfolio in Q3 2026, its #24 holding.
  • Vestal Point Capital first reported a position in Bright Minds Biosciences in Q1 2026 and has held it in 3 quarters since.
  • Vestal Point Capital's Bright Minds Biosciences position peaked at $38.3M in Q2 2026.
  • 110 funds tracked by Wall St. Rank held Bright Minds Biosciences as of Q3 2026.

Based on Vestal Point Capital's 13F filing for Q3 2026, filed 16 Nov 2026.